EUVIMEDOpdag EUVIMED
Crossref

Distinct spatial N‐glycan profiles reveal glioblastoma‐specific signatures

Aaron O Angerstein, Lyndsay E A Young, Thatchawan Thanasupawat, Jerry Vriend, Grace Grimsley, Xueqing Lun, Donna L Senger, Namita Sinha, Jason Beiko, Marshall Pitz, Sabine Hombach-Klonisch, Richard R Drake and 1 more

The Journal of Pathology · 2025-04 · 265 (4) · 486-501

DOI: 10.1002/path.6401 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2025-02-19. Written by Aaron O Angerstein and 12 co-authors. Institution: Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA. Major MEDLINE topics: Polysaccharides, Glioblastoma, Brain Neoplasms. Cited 13 times so far (Crossref); 90 references. Funded by: Natural Sciences and Engineering Council of Canada (NSERC), Natural Sciences and Engineering Research Council of Canada.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This study explored the complex interactions between glycosylation patterns, tumour biology, and therapeutic responses to temozolomide (TMZ) in human malignant glioma, specifically CNS WHO grade 3 oligodendroglioma (ODG) and glioblastoma (GB). Using spatial imaging of N‐glycans in formalin‐fixed paraffin‐embedded (FFPE) tissue sections via MALDI‐MSI, we analysed the N‐glycome in primary and recurrent GB tissues and orthotopic xenografts of patient‐derived brain tumour‐initiating cells (BTIC) sensitive or resistant to TMZ. We identified unique N‐glycosylation profiles, with nontumor brain (NTB) and ODG showing higher levels of bisecting and tri‐antennary structures, while GB exhibited more tetra‐antennary and sialylated N‐glycans. Distinctive sialylation patterns were observed, with specific α2,6 and α2,3 isomeric linkages significantly altered in GB. Moreover, comparative analysis of primary and recurrent GB tissues revealed elevated high mannose N‐glycans in primary GB and fucosylated bi‐ and tri‐antennary N‐glycans in recurrent GB tissues. Next, in the orthotopic xenografts of TMZ‐sensitive and TMZ‐resistant patient brain tumour initiating cells (BTIC), we identified potential N‐glycan markers for TMZ treatment response and resistance. Finally, we found significantly altered expression of genes involved in N‐glycan biosynthesis in malignant glioma, highlighting the crucial role of N‐glycans in glioma and therapy resistance. This study lays the foundation for developing glycosylation‐based diagnostic biomarkers and targeted therapies, potentially improving clinical outcomes for GB patients. © 2025 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

PolysaccharidesGlioblastomaBrain NeoplasmsHumansAnimalsGlycosylationTemozolomideDrug Resistance, NeoplasmBiomarkers, TumorXenograft Model Antitumor AssaysMiceAntineoplastic Agents, AlkylatingSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Author keywords

N‐glycosylationTemozolomidebrain tumour initiating cellsglioblastomagliomamass spectrometry imagingoligodendrogliomaresistance

Substances

PolysaccharidesTemozolomideBiomarkers, TumorAntineoplastic Agents, Alkylating

Authors and institutions

  • Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
  • Department of Human Anatomy and Cell Science, University of Manitoba, Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada.
  • Cumming School of Medicine, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada.
  • Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada.
  • Lady Davis Institute for Medical Research, Montreal, QC, Canada.

ORCID profiles: Thomas Klonisch

Funding

  • Natural Sciences and Engineering Council of Canada (NSERC)
  • Natural Sciences and Engineering Research Council of Canada

Cite

APA

Angerstein, A. O., Young, L. E. A., Thanasupawat, T., Vriend, J., Grimsley, G., Lun, X., Senger, D. L., Sinha, N., Beiko, J., Pitz, M., Hombach-Klonisch, S., Drake, R. R., & Klonisch, T. (2025). Distinct spatial N‐glycan profiles reveal glioblastoma‐specific signatures. The Journal of Pathology, 265(4), 486-501. https://doi.org/10.1002/path.6401

Vancouver

Angerstein AO, Young LEA, Thanasupawat T, Vriend J, Grimsley G, Lun X, et al. Distinct spatial N‐glycan profiles reveal glioblastoma‐specific signatures. The Journal of Pathology. 2025;265(4):486-501. doi:10.1002/path.6401

BibTeX
@article{Angerstein2025,
  author = {Angerstein, Aaron O and Young, Lyndsay E A and Thanasupawat, Thatchawan and Vriend, Jerry and Grimsley, Grace and Lun, Xueqing and Senger, Donna L and Sinha, Namita and Beiko, Jason and Pitz, Marshall and Hombach-Klonisch, Sabine and Drake, Richard R and Klonisch, Thomas},
  title = {Distinct spatial N‐glycan profiles reveal glioblastoma‐specific signatures},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {265},
  number = {4},
  pages = {486--501},
  doi = {10.1002/path.6401}
}
Start for free →